NCVIA National Childhood Vaccine Injury Act
NK natural killer
NMO neuromyelitis optica
OMS opsoclonus myoclonus syndrome
OPV oral polio vaccine
ON optic neuritis
OR odds ratio
ORS oculorespiratory syndrome
PAMP pathogen-associated molecular pattern
PAN polyarteritis nodosa
PCR polymerase chain reaction
PDD pervasive developmental disorder
PEF peak expiratory flow
PFU plaque-forming unit
PR3 proteinase 3
PRP polyribosylribitol phosphate
PRR pattern recognition receptor
RA rheumatoid arthritis
RCT randomized controlled trial
RNA ribonucleic acid
RR relative risk
RT-PCR reverse transcription polymerase chain reaction
SAFEVIC Surveillance of Adverse Events following Vaccination in the Community
SAFEVSS Serious Adverse Events Following Vaccination Surveillance Scheme
SIDS sudden infant death syndrome
SIP sympathetically independent pain
SLE systemic lupus erythematosus
SLEDAI SLE Disease Activity Index
SMP sympathetically maintained pain
SSPE subacute sclerosing panencephalitis
SWHP Scott & White Health Plan
TCR T cell receptor
TF tissue factor
TIV trivalent inactivated influenza vaccine
TT tetanus toxoid


The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement